BAKER BROS. ADVISORS LP – Neoleukin Therapeutics, Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$2.44M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
-37.86%
quarter
Neoleukin Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -1.49M | $0.64 | 3.82M | |
| Q2 2022 | share | 0.00% | 0 shares | -3.24M | $1.03 | 3.82M | |
| Q1 2022 | share | 0.00% | 0 shares | -11.23M | $1.88 | 3.82M | |
| Q4 2021 | share | 0.00% | 0 shares | -9.21M | $5.1 | 3.82M | |
| Q3 2021 | share | 0.00% | 0 shares | -7.64M | $7.23 | 3.82M | |
| Q2 2021 | share | 0.00% | 0 shares | -11.77M | $9.23 | 3.82M | |
| Q1 2021 | share | 0.00% | 0 shares | -6.84M | $12.31 | 3.82M | |
| Q4 2020 | share | 0.00% | 0 shares | 8.02M | $14.1 | 3.82M | |
| Q3 2020 | share | Increase | +12.48% | 424K shares | -10.54M | $12 | 3.82M |
| Q2 2020 | share | 0.00% | 0 shares | 17.73M | $16.6 | 3.39M | |
| Q1 2020 | share | 0.00% | 0 shares | -3.19M | $11.38 | 3.39M | |
| Q4 2019 | share | Decrease | -69.95% | -7.90M shares | 9.63M | $12.32 | 3.39M |
| Q3 2019 | share | Increase | 0.00% | 11.30M shares | 32.22M | $2.85 | 11.30M |